• Milan court denied minority shareholders’ bid to temporarily suspend a capital increase tied to Genenta’s ATC acquisition.
• The order is dated Oct. 2, 2026, with notice to the company on Oct. 5, 2026.
• The share issuance remains in effect pending a merits ruling, subject to any appeal of the interim order.
• Judges found no clear evidence of unlawful board conduct warranting interim relief at this stage.
• The underlying civil case challenging the May 18, 2026 capital increase remains pending.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genenta Science S.p.A. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-046136), on October 07, 2026, and is solely responsible for the information contained therein.